Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma

Completed

• Conditions: Duodenal Cancer
• Interventions: Procedure: Pancreaduodenectomy and possible adjuvant therapy

• Registration Number: NCT05134961
• Lead Sponsor: Bispebjerg Hospital

Brief Summary

The aim of this study is to examine the long-term outcomes after curatively intended resection of duodenal adenocarcinoma.

Detailed Description

Not available

Study Timeline

• Study Start: 1999-01-01
• Primary Completion: 2020-08-31
• Study Completion: 2021-09-30
• Status Verified: 2021-11
• Study First Submitted: 2021-11-16
• Study First Submitted QC: 2021-11-16
• Last Update Submitted: 2021-11-16
• Study First Posted: 2021-11-26
• Last Update Posted: 2021-11-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 113

Inclusion Criteria

• Patients subjected to resection of primary duodenal adenocarcinoma

Exclusion Criteria

• None.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients undergoing resection of primary duodenal cancer	Pancreaduodenectomy and possible adjuvant therapy	Tumors comprised histologically confirmed adenocarcinomas in the duodenum excluding adenocarcinoma of the ampulla of Vater and adenocarcinomas with gastric and pancreato-biliary morphology and immunohistochemistry.

Primary Outcome Measures

Name	Time	Method
3-year survival	Three years	Cumulative survival after three years

Secondary Outcome Measures

Name	Time	Method
Duodenal cancer recurrence	5 years	Recurrence found by computed tomography scan

Trial Locations

Locations (1)

Kristian Schaumburg Kiim; 🇩🇰 Copenhagen NV, Copenhagen, Denmark